Evaluation of clinical effects and plasma metabolomic profiles after the administration of grapiprant in dogs affected by osteoarthritis: a prospective, off–on–off, clinical study
IntroductionOsteoarthritis (OA) is a prevalent cause of chronic pain and impaired mobility in dogs. Grapiprant, an EP4 prostaglandin receptor antagonist, represents a novel therapeutic option with a favorable safety profile compared to traditional NSAIDs.AimTo evaluate the clinical efficacy of grapi...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2026-06-01
|
| Schriftenreihe: | Frontiers in Veterinary Science |
| Schlagworte: | |
| Online-Zugang: | https://www.frontiersin.org/articles/10.3389/fvets.2026.1811478/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|